Taku Matsubara

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Inhibition of cardiac sarcolemma Na+?K+ ATPase by oxyradical generating systems

Qiming Shao, Taku Matsubara, Sunil K. Bhatt et al. · Molecular and Cellular Biochemistry · 1995 · 56 citations

Life Sciences, Biochemistry, Pharmacology +5

Negative NO3− difference in human coronary circulation with severe atherosclerotic stenosis

Takaharu Ishibashi, Taku Matsubara, Toru Ida et al. · Life Sciences · 1999 · 47 citations

Medicine, Cardiology, Physiology +7

Plasma Levels of Soluble Thrombomodulin, C-reactive Protein, and Serum Amyloid A Protein in the Atherosclerotic Coronary Circulation

Tohru Mezaki, Taku Matsubara, Tomoyuki Hori et al. · Japanese Heart Journal · 2003 · 35 citations · Full text

Medicine, Cardiology, Clinical Sciences +17

Protective effect of vanadate on oxyradical-induced changes in isolated perfused heart

Taku Matsubara, Sorin Musat‐Marcu, Hara P. Misra et al. · Molecular and Cellular Biochemistry · 1995 · 34 citations

Life Sciences, Pharmacology, Physiology +5